Substituted 4-aryl-chromene as activator of caspases and inducer of apoptosis and as antivascular agent and the use thereof

Details for Australian Patent Application No. 2007271743 (hide)

Owner CYTOVIA, INC.

Inventors Labrecque, Denis; Kasibhatla, Shailaja; Drewe, John A.; Tseng, Ben Y.; Gourdeau, Henriette; Kemnitzer, William E.; Cai, Sui Xiong; Blais, Charles

Agent Houlihan2

Pub. Number AU-B-2007271743

PCT Pub. Number WO2008/005572

Priority 60/806,674 06.07.06 US

Filing date 6 July 2007

Wipo publication date 10 January 2008

Acceptance publication date 26 July 2012

International Classifications

C07D 311/58 Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

A61K 31/353

Event Publications

26 February 2009 PCT application entered the National Phase

  PCT publication WO2008/005572 Priority application(s): WO2008/005572

26 July 2012 Application Accepted

  Published as AU-B-2007271743

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007271749-Crystalline nemorubicin hydrochloride

2007271741-Real-time monitoring and control of physical and arousal status of individual organisms